These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30694827)

  • 1. Triglycerides and triglyceride-rich lipoproteins in the development and progression of atherosclerosis.
    Generoso G; Janovsky CCPS; Bittencourt MS
    Curr Opin Endocrinol Diabetes Obes; 2019 Apr; 26(2):109-116. PubMed ID: 30694827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triglycerides and Triglyceride-Rich Lipoproteins in the Causal Pathway of Cardiovascular Disease.
    Budoff M
    Am J Cardiol; 2016 Jul; 118(1):138-45. PubMed ID: 27184174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Triglycerides in Atherosclerosis: Recent Pathophysiologic Insights and Therapeutic Implications.
    Akivis Y; Alkaissi H; McFarlane SI; Bukharovich I
    Curr Cardiol Rev; 2024; 20(2):39-49. PubMed ID: 38288833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.
    Nordestgaard BG
    Circ Res; 2016 Feb; 118(4):547-63. PubMed ID: 26892957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triglycerides and ASCVD Risk Reduction: Recent Insights and Future Directions.
    Hussain A; Ballantyne CM; Saeed A; Virani SS
    Curr Atheroscler Rep; 2020 Jun; 22(7):25. PubMed ID: 32494924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triglycerides and risk of atherosclerotic cardiovascular disease: An update.
    Farnier M; Zeller M; Masson D; Cottin Y
    Arch Cardiovasc Dis; 2021 Feb; 114(2):132-139. PubMed ID: 33546998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triglyceride-rich lipoproteins and progression of atherosclerosis.
    Hodis HN; Mack WJ
    Eur Heart J; 1998 Feb; 19 Suppl A():A40-4. PubMed ID: 9519342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?
    Dallinga-Thie GM; Kroon J; Borén J; Chapman MJ
    Curr Cardiol Rep; 2016 Jul; 18(7):67. PubMed ID: 27216847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease risk: current status and treatments.
    Reyes-Soffer G
    Curr Opin Endocrinol Diabetes Obes; 2021 Apr; 28(2):85-89. PubMed ID: 33481422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
    Botham KM; Wheeler-Jones CP
    Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial triglyceride-rich lipoproteins promote lipid accumulation and apolipoprotein B-48 receptor transcriptional activity in human circulating and murine bone marrow neutrophils in a fatty acid-dependent manner.
    Ortega-Gómez A; Varela LM; López S; Montserrat de la Paz S; Sánchez R; Muriana FJG; Bermúdez B; Abia R
    Mol Nutr Food Res; 2017 Sep; 61(9):. PubMed ID: 28322000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease.
    Rosenson RS; Davidson MH; Hirsh BJ; Kathiresan S; Gaudet D
    J Am Coll Cardiol; 2014 Dec; 64(23):2525-40. PubMed ID: 25500239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on remnant-like particle cholesterol from the MARINE and ANCHOR studies.
    Ballantyne CM; Bays HE; Philip S; Doyle RT; Braeckman RA; Stirtan WG; Soni PN; Juliano RA
    Atherosclerosis; 2016 Oct; 253():81-87. PubMed ID: 27596132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk reduction with icosapent ethyl.
    Patel PN; Patel SM; Bhatt DL
    Curr Opin Cardiol; 2019 Nov; 34(6):721-727. PubMed ID: 31464773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
    Oscarsson J; Hurt-Camejo E
    Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women.
    Bansal S; Buring JE; Rifai N; Mora S; Sacks FM; Ridker PM
    JAMA; 2007 Jul; 298(3):309-16. PubMed ID: 17635891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triglycerides and heart disease: still a hypothesis?
    Goldberg IJ; Eckel RH; McPherson R
    Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1716-25. PubMed ID: 21527746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diabetic dyslipidaemia and the atherosclerosis].
    Márk L; Dani G
    Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Therapies for Lowering Triglyceride-Rich Lipoproteins: JACC Focus Seminar 3/4.
    Rosenson RS; Shaik A; Song W
    J Am Coll Cardiol; 2021 Nov; 78(18):1817-1830. PubMed ID: 34711341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of potentially atherogenic triglyceride-rich lipoprotein particles].
    Alaupovic P; Blankenhorn DH
    Klin Wochenschr; 1990; 68 Suppl 22():38-42. PubMed ID: 2087077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.